Travel Time to Treating Facility and Mortality in Men With Prostate Cancer.

ABSTRACT:

Importance

Geographic access to prostate cancer care may influence outcomes but is often measured using straight-line distance, which may not accurately capture the travel burden experienced by patients.

Objective

To evaluate the association between estimated travel time from patients' residence to treatment facilities and all-cause and prostate cancer-specific mortality.

Design, setting, and participants

This retrospective cohort study used data from the Multilevel Epidemiologic Tumor Registry for Oncology, a nationally representative, investigator-initiated, population-based cancer registry that integrates geomasked residential and treatment facility information from multiple US state cancer registries. The study included patients aged 40 to 99 years from Hawaii, Lo

SUBMITTER: Korn SM 

PROVIDER: S-EPMC12676350 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature